Skip to Content

A/P 12.5/15 (Oseni 12.5 mg / 15 mg)

Generic Name: alogliptin/pioglitazone

Pill with imprint A/P 12.5/15 is Yellow, Round and has been identified as Oseni 12.5 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 12.5/15

Oseni

Generic Name:
alogliptin/pioglitazone
Imprint:
A/P 12.5/15
Strength:
12.5 mg / 15 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0121

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide